Evidence map›Paper›PMID 39303219›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Mitochondrial Dysfunction-Evoked DHODH Acetylation is Involved in Renal Cell Ferroptosis during Cisplatin-Induced Acute Kidney Injury.

Nan-Nan Liang, Yue-Yue Guo, Xiao-Yi Zhang, Ya-Hui Ren, Yi-Zhang He, Zhi-Bing Liu, De-Xiang Xu, Shen Xu

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. CoQExperimental & molecular medicine · 2026
    Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Nan-Nan LiangDepartment of Toxicology, Anhui Medical University, Hefei, China, 230032.
Yue-Yue GuoDepartment of Toxicology, Anhui Medical University, Hefei, China, 230032.
Xiao-Yi ZhangDepartment of Toxicology, Anhui Medical University, Hefei, China, 230032.
Ya-Hui RenDepartment of Urology, the Second Affiliated Hospital of Anhui Medical University, Hefei, China, 230601.
Yi-Zhang HeDepartment of Urology, the Second Affiliated Hospital of Anhui Medical University, Hefei, China, 230601.
Zhi-Bing LiuDepartment of Blood Transfusion, Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, 230601, China.
De-Xiang XuDepartment of Toxicology, Anhui Medical University, Hefei, China, 230032.ORCID 0000-0002-5126-4335
Shen XuDepartment of Urology, the Second Affiliated Hospital of Anhui Medical University, Hefei, China, 230601.ORCID 0000-0002-0520-9511

Funding

Anhui Provincial Natural Science Foundation 2208085QH237National Natural Science Foundation of China 82204493Promotion project of basic and clinical collaborative research from Anhui Medical University 2020xkjT038
6 · The paper itself

Abstract

Several studies have observed renal cell ferroptosis during cisplatin-induced acute kidney injury (AKI). However, the mechanism is not completely clear. In this study, oxidized arachidonic acid (AA) metabolites are increased in cisplatin-treated HK-2 cells. Targeted metabolomics showed that the end product of pyrimidine biosynthesis is decreased and the initiating substrate of pyrimidine biosynthesis is increased in cisplatin-treated mouse kidneys. Mitochondrial DHODH, a key enzyme for pyrimidine synthesis, and its downstream product CoQH

Indexed as

Acute Kidney InjuryCisplatinFerroptosisMitochondriaAcetylationAnimalsCell LineDisease Models, AnimalHumansMaleMiceMice, Inbred C57BLSirtuin 3CisplatinSirtuin 3acute kidney injurycisplatinDHODH acetylationferroptosisSIRT3 SUMOylation

Identifiers

PMID39303219
PMCPMC11578349

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.